Skip to main content
. 2018 Dec 5;7:205. doi: 10.1038/s41426-018-0201-3

Fig. 5. The clinical symptoms, asymptomatic (%), survival (%), and body weight change (%) of different EV-A71 Tg mouse models.

Fig. 5

Three-week-old hSCARB2 KI mice were inoculated I.C. with DMEM/ EV-A71 (a) or inoculated intravenous (I.V.) with DMEM/EV-A71 (b) respectively. Three-week-old hSCARB2 KI mice were inoculated with CMU4232 (c) /CDV-Isehara (d) strain via I.C. or I.V. route respectively. (1) The clinical symptoms, (2) asymptomatic (%), (3) survival (%), and (4) body weight change (%) of the Tg mice were observed and recorded daily for 2 weeks after viral infection. ***p,0.000. I.C. intracerebral, I.V. intravenous